Agency Header

Pharmaceutical and Therapeutics Committee

The Medicaid P & T Committee is comprised of up to 15 actively practicing healthcare professionals appointed by the Secretary of DHHR and acts in an advisory capacity to assist BMS in selecting drugs for the Preferred Drug List.  Members may serve a maximum of three, three-year terms.  Members are required to disclose their conflicts of interest, if any, and to maintain confidentiality of drug rebate information.  The Committee meets three times per year and as necessary to review the PDL and new drugs as they become available.

Meeting Agendas and Minutes: 

  2015 Meetings         
  January 28, 2015  Agenda  Minutes Draft PDL for Review  
  2014 Meetings        
   October 22, 2014 Agenda Minutes Draft PDL for review  
   August 27, 2014 Agenda  Minutes Draft PDL for review  
   April 23, 2014 Agenda  Minutes Draft PDL for review  
   January 29, 2014 Agenda   Minutes Draft PDL for review  
   2013 Meetings        
   October 23, 2013  Agenda  Minutes  Draft PDL for review  
   August 28, 2013  Meeting Cancelled    
   April 24, 2013  Agenda  Minutes Draft PDL for review  
   January 30, 2013  Agenda  Minutes Draft PDL for review   
  Archived P & T Agendas and Meetings  
Follow us on Facebook